N-(4-chlorophenyl)-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4-methyl-6-oxopyridazine-3-carboxamide
C29H23ClN4O5 — CID 171780286
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-chlorophenyl)-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4-methyl-6-oxopyridazine-3-carboxamide
N-(4-chlorophenyl)-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4-methyl-6-oxopyridazine-3-carboxamide (PubChem CID 171780286) has the molecular formula C29H23ClN4O5 and a molecular weight of 542.98 g/mol. Its IUPAC name is N-(4-chlorophenyl)-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4-methyl-6-oxopyridazine-3-carboxamide.
Molecular Properties
| Compound Name | N-(4-chlorophenyl)-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4-methyl-6-oxopyridazine-3-carboxamide |
|---|---|
| PubChem CID | 171780286 |
| Molecular Formula | C29H23ClN4O5 |
| Molecular Weight | 542.98 g/mol |
| Exact Mass | 542.14 |
| IUPAC Name | N-(4-chlorophenyl)-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4-methyl-6-oxopyridazine-3-carboxamide |
| SMILES | COc1cc2nccc(Oc3ccc(-n4nc(C(=O)Nc5ccc(Cl)cc5)c(C)cc4=O)cc3)c2cc1OC |
| InChI | InChI=1S/C29H23ClN4O5/c1-17-14-27(35)34(33-28(17)29(36)32-19-6-4-18(30)5-7-19)20-8-10-21(11-9-20)39-24-12-13-31-23-16-26(38-3)25(37-2)15-22(23)24/h4-16H,1-3H3,(H,32,36) |
| InChIKey | JXUFZJJPSZRVHG-UHFFFAOYSA-N |
| XLogP | 5.80 |
| TPSA | 104.57 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 542.98 |
| LogP ≤ 5 | 5.80 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171780286 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.